Flavia Borellini

Board Member at Cantargia

Flavia Borellini holds a Ph.D. in Pharmaceutical Chemistry and Technology from the University of Modena, Italy.

She has broad experience in oncology and other therapeutic areas and has held senior positions with Astra Zeneca (Global Franchise Head, Hematology and Vice President, Global Product and Portfolio Strategy), Acerta Pharma (CEO), ONYX Pharmaceuticals (Vice President, Program Leadership), and Roche (Lifecycle Leader).


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Cantargia

1 followers

Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.


Industries

Employees

11-50

Links